The rise of appetite-suppressing drugs like Ozempic is changing the way Americans eat, but there's a twist: cannabis ...
One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks.
A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...